Topic
Antitrust Enforcement
397 published works
Cleary Antitrust Watch
Antitrust Review Episode 19: In Conversation With Bruce Hoffman & Dave Gelfand
In the latest instalment of the Cleary Gottlieb Antitrust Review podcast, host Nick Levy is joined by Bruce Hoffman, Director of the Federal Trade Commission’s Bureau of Competition between August…
Life Sciences Perspectives
United States: Trends of Agency Scrutiny on Pharmaceutical Transactions Expected to Shift Amid Rise in Deal Activity (GCR)
Despite the threatening rhetoric, the early years of the Biden Administration largely followed previous regimes with respect to antitrust enforcement in the life sciences space. Pharmaceutical transactions in particular encounters…
The CLS Blue Sky Blog
Morrison & Foerster Discusses Antitrust Actions for Third Quarter 2023
By Lisa Phelan, Megan Gerking, Joseph Folio, Rob Manoso, Megan Golden
The third quarter of 2023 was eventful for both domestic and international cartel enforcers. In the United States, the Department of Justice (DOJ) continues to revamp policies to sharpen its…
Life Sciences Perspectives
Antitrust & Competition Life Sciences Quarterly Update Q3 2023
The third quarter in the life sciences space saw notable developments in significant agency enforcement actions: The FTC abandoned its pursuit of a novel theory and settled its Amgen/Horizon lawsuit…
Covington Competition
GAO Recommends Increased Guidance for DOD Mergers & Acquisitions Review
On October 17, 2023, the U.S. Government Accountability Office (“GAO”) published a report on mergers and acquisitions (“M&A”) in the defense industrial base. The report details the current M&A review…
Cleary Antitrust Watch
Antitrust Review Episode 18: In Conversation With Alberto Bacchiega
In the latest episode of Cleary’s Antitrust Review, host Nick Levy is joined by Alberto Bacchiega, Director of the Commission’s Digital Platforms Directorate, which is charged with implementing the EU’s…
Blog of Reason
The Federal Trade Commission and the U.S. DOJ Antitrust Division during the Biden Administration Have Significantly Ramped Up Antitrust Enforcement: Non-Antitrust Lawyers Beware!
By Wiggin and Dana, Robert Langer
Senior Counsel Robert M. Langer and Michael A. Kurs of Pullman & Comley have co-authored an article titled, “The Federal Trade Commission and the U.S. DOJ Antitrust Division during the Biden Administration…
Life Sciences Perspectives
Antitrust & Competition Life Sciences Quarterly Update Q2 2023
The second quarter saw significant enforcement and dealmaking in the life sciences space. The Federal Trade Commission (FTC) announced its attempt to block Amgen/Horizon, the first such challenge to a…
State AG Blog
State AG Updates: July 20-26, 2023
Each week, Crowell & Moring’s State Attorneys General team highlights significant actions that State AGs have taken. Here are this week’s updates. Multistate A bipartisan coalition of 32 attorneys general…
The Contingency
Big Boost in Antitrust Funding Won’t Happen in 2023
The near-term prospects for significantly boosting antitrust enforcement appropriations look doubtful. As I mentioned last month in Antitrust Enforcers Must Have More Funding, the Antitrust Division in the Department of…